Indian Court Won't Block Generic Nexavar
An Indian court has reportedly denied an appeal by Bayer AG that sought to block the sale of a generic version of its cancer drug Nexavar, the latest in a series...To view the full article, register now.
Already a subscriber? Click here to view full article